Clinical Outcomes of Radiologic Relapse in Patients With Cardiac Sarcoidosis Under Immunosuppressive Therapies.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 03 06 2022
revised: 12 10 2022
accepted: 24 10 2022
pubmed: 4 12 2022
medline: 28 12 2022
entrez: 3 12 2022
Statut: ppublish

Résumé

Although nuclear imaging can detect cardiac involvement of cardiac sarcoidosis (CS), including subclinical states, little is known about the prevalence and outcomes of radiologic relapse under prednisolone (PSL) therapy. This study aimed to investigate the clinical characteristics and outcomes in patients with radiologic relapse. A total of 80 consecutive patients with CS whose disease activity on nuclear imaging decreased at least once after initiation of immunosuppressive therapy were identified through a retrospective chart review. Radiologic relapse of CS was diagnosed using

Identifiants

pubmed: 36462271
pii: S0002-9149(22)01169-9
doi: 10.1016/j.amjcard.2022.10.048
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-29

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Kohei Kaneta (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Hiroyuki Takahama (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: hiroytakahama@gmail.com.

Emi Tateishi (E)

Department of Radiology and Nuclear Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Yuki Irie (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Kenji Moriuchi (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Masashi Amano (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Atsushi Okada (A)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Makoto Amaki (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Keisuke Kiso (K)

Department of Radiology and Nuclear Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Hideaki Kanzaki (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Kengo Kusano (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Chisato Izumi (C)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH